These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38586690)

  • 1. Rifampicin Resistance Pattern of Mycobacterium tuberculosis Infection in Tertiary Care Hospital Settings.
    Ranganathan A; Carmelin DS; Muthusamy R
    Cureus; 2024 Mar; 16(3):e55755. PubMed ID: 38586690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of GeneXpert Mycobacterium tuberculosis/rifampicin for rapid detection of rifampicin resistant Mycobacterium tuberculosis strains of clinically suspected multi-drug resistance tuberculosis cases.
    Guenaoui K; Harir N; Ouardi A; Zeggai S; Sellam F; Bekri F; Cherif Touil S
    Ann Transl Med; 2016 May; 4(9):168. PubMed ID: 27275481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of GeneXpert
    Habous M; E Elimam MA; Kumar R; L Deesi ZA
    Int J Mycobacteriol; 2019; 8(2):132-137. PubMed ID: 31210154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the GeneXpert MTB/RIF assay on extrapulmonary and respiratory samples other than sputum: a low burden country experience.
    Pandey S; Congdon J; McInnes B; Pop A; Coulter C
    Pathology; 2017 Jan; 49(1):70-74. PubMed ID: 27913043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic utility of GeneXpert MTB/RIF assay versus conventional methods for diagnosis of pulmonary and extra-pulmonary tuberculosis.
    Elbrolosy AM; El Helbawy RH; Mansour OM; Latif RA
    BMC Microbiol; 2021 May; 21(1):144. PubMed ID: 33980173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the Diagnostic Utility of GeneXpert Mycobacterium tuberculosis/Rifampicin (MTB/RIF) Assay in the Suspected Cases of Tuberculous Meningitis.
    Patel S; Dadheech M; Maurya AK; Singh J; Purwar S; Rai N; Sarawagi R; Joshi A; Khadanga S
    Cureus; 2023 Apr; 15(4):e37761. PubMed ID: 37213979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GeneXpert
    Christopher PM; ; Widysanto A
    Int J Mycobacteriol; 2019; 8(4):351-358. PubMed ID: 31793505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular diagnosis, genetic diversity and drug sensitivity patterns of Mycobacterium tuberculosis strains isolated from tuberculous meningitis patients at a tertiary care hospital in South India.
    Krishnakumariamma K; Ellappan K; Muthuraj M; Tamilarasu K; Kumar SV; Joseph NM
    PLoS One; 2020; 15(10):e0240257. PubMed ID: 33017455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of GeneXpert MTB/RIF for determination of rifampicin resistance among new tuberculosis cases in west and northwest Iran.
    Atashi S; Izadi B; Jalilian S; Madani SH; Farahani A; Mohajeri P
    New Microbes New Infect; 2017 Sep; 19():117-120. PubMed ID: 28794886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Mycobacterium tuberculosis in AFB smear-negative sputum specimens through MTB culture and GeneXpert
    Rasool G; Khan AM; Mohy-Ud-Din R; Riaz M
    Int J Immunopathol Pharmacol; 2019; 33():2058738419827174. PubMed ID: 30791749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study the prevalence of rifampicin resistance among pulmonary tuberculosis patients by genexpert assay from a tertiary care hospital of North India.
    Devrari JC; Chauhan M
    Int J Mycobacteriol; 2023; 12(2):175-178. PubMed ID: 37338480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of rifampicin-resistant mycobacterium tuberculosis by GeneXpert MTB/RIF assay and its correlates among 2605 probable tuberculosis patients in upper Egypt.
    Hassanin ESA; Mohamed Hussein AA; Abdelrheem SS; Dongol E; Mhsb AHA; Zahran AM; Zein M; G Sayed I
    Indian J Tuberc; 2023 Jul; 70(3):345-355. PubMed ID: 37562911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of GeneXpert MTB/RIF system performances in the diagnosis of extrapulmonary tuberculosis.
    Mechal Y; Benaissa E; El Mrimar N; Benlahlou Y; Bssaibis F; Zegmout A; Chadli M; Malik YS; Touil N; Abid A; Maleb A; Elouennass M
    BMC Infect Dis; 2019 Dec; 19(1):1069. PubMed ID: 31856744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of molecular detection of extrapulmonary tuberculosis and resistance to rifampicin with GeneXpert® MTB/RIF.
    Marouane C; Smaoui S; Kammoun S; Slim L; Messadi-Akrout F
    Med Mal Infect; 2016 Feb; 46(1):20-4. PubMed ID: 26654321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic performance of GeneXpert MTB/RIF in detecting MTB in smear-negative presumptive TB patients.
    Rimal R; Shrestha D; Pyakurel S; Poudel R; Shrestha P; Rai KR; Ghimire GR; Rai G; Rai SK
    BMC Infect Dis; 2022 Apr; 22(1):321. PubMed ID: 35365080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of the REBA MTB-Rifa® assay for rapid detection of rifampicin resistant Mycobacterium tuberculosis.
    Cho E; Shamputa IC; Kwak HK; Lee J; Lee M; Hwang S; Jeon D; Kim CT; Cho S; Via LE; Barry CE; Lee JS
    BMC Infect Dis; 2013 Oct; 13():478. PubMed ID: 24128118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the GeneXpert MTB/RIF assay performance in sputum samples with various characteristics from presumed pulmonary tuberculosis patients in Shiselweni region, Eswatini.
    Mulengwa DL; Monyama MC; Lebelo SL
    Infect Dis (Lond); 2022 Mar; 54(3):170-177. PubMed ID: 34705574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of an indigenous assay for rapid molecular detection of rifampicin resistance in presumptive multidrug-resistant pulmonary tuberculosis patients.
    Gomathi NS; Singh M; Myneedu VP; Chauhan DS; Tripathy S; Sarin R; Mohan A; Bhatnagar A; Khangembam JS; Kannan T; V Rao MV; Logani J; Dey B; Gangakhedkar RR; Swaminathan S; Singh UB
    Indian J Med Res; 2020 Nov; 152(5):482-489. PubMed ID: 33707390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert® MTB/RIF in Kampala, Uganda: a retrospective study.
    Mboowa G; Namaganda C; Ssengooba W
    BMC Infect Dis; 2014 Sep; 14():481. PubMed ID: 25190040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of isoniazid resistance in cases of rifampicin resistance detected on GeneXpert MTB/RIF assay.
    Katoch CDS; Peter DK; Marwah V; Kumar K; Bhati G
    Med J Armed Forces India; 2023 Dec; 79(Suppl 1):S1-S5. PubMed ID: 38144631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.